The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 07, 2020

Filed:

May. 19, 2016
Applicant:

Genofocus Co., Ltd., Daejeon, KR;

Inventors:

Su Jin Kim, hungcheongnam-do, KR;

Young-Jae Eu, Daejeon, KR;

Taek Ho Yang, Daejeon, KR;

Jae Gu Pan, Sejong-si, KR;

Eui Joong Kim, Daejeon, KR;

Assignee:

GENOFOCUS CO., LTD., Daejeon, KR;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 9/24 (2006.01); C12P 19/04 (2006.01); C12N 15/75 (2006.01); C12N 15/80 (2006.01); C12N 15/81 (2006.01); C12P 19/14 (2006.01);
U.S. Cl.
CPC ...
C12N 9/2402 (2013.01); C12N 15/75 (2013.01); C12N 15/80 (2013.01); C12N 15/81 (2013.01); C12P 19/04 (2013.01); C12P 19/14 (2013.01); C12Y 302/01023 (2013.01);
Abstract

The present invention relates to a beta-galactosidase mutant having high transglycosylation activity and containing a C-terminal deletion, and the use thereof and more. More specifically, the present invention relates to a beta-galactosidase mutant having a C-terminal deletion, a gene encoding the same, a recombinant vector containing the gene, a recombinant microorganism transformed with the gene or the recombinant vector, and a method for producing the beta-galactosidase mutant using the recombinant microorganism. Using the high transglycosylation activity of the beta-galactosidase mutant containing the C-terminal deletion according to the present invention, galactooligosaccharide can be efficiently produced in large amounts.


Find Patent Forward Citations

Loading…